110 results
D
INBS
Intelligent Bio Solutions Inc
22 Mar 24
$10.10 mm in equity / options, sold $10.10 mm, 8 investors
10:00am
of this Form D are "covered securities" for purposes
of NSMIA, whether in all instances or due to the nature of the offering that is the subject
8-K
EX-10.2
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
not be deemed to limit or affect any of the provisions hereof.
(m) Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder
8-K
EX-10.1
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned … or such enforcement or setoff had not occurred.
5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any
8-K
EX-99.1
sy7ph3 ynz
5 Oct 23
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
5:25pm
8-K
EX-1.1
awwr xkjyk
4 Oct 23
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
5:27pm
424B4
62scvrc54fz wj992qp
3 Oct 23
Prospectus supplement with pricing info
4:52pm
8-K
EX-99.1
h2lxe qkw84glonubw0
21 Sep 23
Regulation FD Disclosure
5:20pm